XENDIO Trademark

Trademark Overview

On Friday, May 17, 2019, a trademark application was filed for XENDIO with the United States Patent and Trademark Office. The USPTO has given the XENDIO trademark a serial number of 88435375. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 28, 2022. This trademark is owned by Pfizer Inc.. The XENDIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
xendio

General Information

Serial Number88435375
Word MarkXENDIO
Filing DateFriday, May 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, February 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, June 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 2, 2021EXTENSION 3 GRANTED
Wednesday, June 2, 2021EXTENSION 3 FILED
Wednesday, June 2, 2021TEAS EXTENSION RECEIVED
Saturday, December 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020EXTENSION 2 GRANTED
Thursday, December 3, 2020EXTENSION 2 FILED
Thursday, December 3, 2020TEAS EXTENSION RECEIVED
Saturday, May 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2020EXTENSION 1 GRANTED
Thursday, May 28, 2020EXTENSION 1 FILED
Thursday, May 28, 2020TEAS EXTENSION RECEIVED
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 30, 2019ASSIGNED TO LIE
Thursday, October 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 22, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 22, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 22, 2019NON-FINAL ACTION E-MAILED
Saturday, June 22, 2019NON-FINAL ACTION WRITTEN
Saturday, June 22, 2019ASSIGNED TO EXAMINER
Monday, June 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 21, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

xendio preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases